Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 5:46 pm Sale | 13G | CELCUITY INC CELC | Venrock Healthcare Capital Partners III L.P. | 0 0.000% | -2,476,980 (Position Closed) | View |
| 2024-11-14 5:46 pm Unchanged | 13G | CELCUITY INC CELC | RA CAPITAL MANAGEMENT L.P. | 1,286,960 3.400% | 0 (Unchanged) | View |
| 2024-11-14 4:26 pm Purchase | 13G | CELCUITY INC CELC | BAKER BROS. ADVISORS LP | 1,874,978 5.100% | 1,874,978 (New Position) | View |
| 2024-11-14 4:05 pm Sale | 13G | CELCUITY INC CELC | COMMODORE CAPITAL LP | 2,217,982 5.900% | -274,904 (-11.03%) | View |
| 2024-11-14 3:35 pm Purchase | 13G | CELCUITY INC CELC | Soleus Private Equity Fund II L.P. | 3,931,800 9.900% | 3,931,800 (New Position) | View |
| 2024-10-07 4:26 pm Sale | 13G | CELCUITY INC CELC | MORGAN STANLEY MS | 1,391,552 3.800% | -803,474 (-36.60%) | View |
| 2024-06-10 5:01 pm Purchase | 13G | CELCUITY INC CELC | BIOTECHNOLOGY VALUE FUND L P | 3,466,000 9.900% | 3,466,000 (New Position) | View |
| 2024-02-14 8:28 pm Purchase | 13G | CELCUITY INC CELC | Venrock Healthcare Capital Partners III L.P. | 2,476,980 9.990% | 2,476,980 (New Position) | View |
| 2024-02-14 5:01 pm Sale | 13G | CELCUITY INC CELC | RA CAPITAL MANAGEMENT L.P. | 1,286,960 5.000% | -962,461 (-42.79%) | View |
| 2024-02-14 4:34 pm Purchase | 13G | CELCUITY INC CELC | PERCEPTIVE ADVISORS LLC | 1,481,300 6.100% | 40,000 (+2.78%) | View |
| 2024-02-14 4:05 pm Purchase | 13G | CELCUITY INC CELC | COMMODORE CAPITAL LP | 2,492,886 9.900% | 235,474 (+10.43%) | View |
| 2024-02-12 11:55 am Purchase | 13G | CELCUITY INC CELC | MORGAN STANLEY MS | 2,195,026 9.100% | 1,103,185 (+101.04%) | View |
| 2024-02-09 10:32 am Purchase | 13G | CELCUITY INC CELC | Soleus Capital Master Fund L.P. | 2,623,890 9.900% | 338,336 (+14.80%) | View |
| 2024-02-07 5:15 pm Purchase | 13G | CELCUITY INC CELC | Laing Lance G. | 1,421,036 5.500% | 47,289 (+3.44%) | View |
| 2024-02-07 5:15 pm Purchase | 13G | CELCUITY INC CELC | Sullivan Brian F. | 3,648,665 14.000% | 168,385 (+4.84%) | View |
| 2023-12-26 4:15 pm Purchase | 13G | CELCUITY INC CELC | PERCEPTIVE ADVISORS LLC | 1,441,300 5.700% | 1,441,300 (New Position) | View |
| 2023-02-14 4:45 pm Purchase | 13G | CELCUITY INC CELC | RA CAPITAL MANAGEMENT L.P. | 2,249,421 9.900% | 762,950 (+51.33%) | View |
| 2023-02-14 4:05 pm Purchase | 13G | CELCUITY INC CELC | COMMODORE CAPITAL LP | 2,257,412 9.900% | 1,336,948 (+145.25%) | View |
| 2023-02-14 4:05 pm Purchase | 13G | CELCUITY INC CELC | Venrock Healthcare Capital Partners II L.P. | 2,171,125 9.990% | 513,392 (+30.97%) | View |
| 2023-02-14 08:00 am Purchase | 13G | CELCUITY INC CELC | Soleus Capital Master Fund L.P. | 2,285,554 9.900% | 1,337,165 (+140.99%) | View |